Your browser doesn't support javascript.
loading
Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma.
Shen, Sherry; Rubinstein, Maria M; Park, Kay J; Konner, Jason A; Makker, Vicky.
Afiliación
  • Shen S; Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Rubinstein MM; Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Park KJ; Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Konner JA; Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Makker V; Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Gynecol Oncol Rep ; 37: 100844, 2021 Aug.
Article en En | MEDLINE | ID: mdl-34430690
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Gynecol Oncol Rep Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Gynecol Oncol Rep Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos